Top Pharmaceutical Companies in Washington, DC (19)
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
Bluesight enables hospital operations with intelligence that simplifies inventory management, procurement, and compliance. Through its suite of industry-leading, AI-powered solutions, Bluesight ensures that health systems protect every patient and optimize every dollar. Over 3,000 United States and Canadian hospitals rely on Bluesight every day. For more information, please visit bluesight.com. Bluesight's solutions include: KitCheck (inventory management), CostCheck (purchasing optimization), ControlCheck (diversion...
Bluesight's Top Stability & Growth Strengths
Strong Market Position & Advantage: Market leadership is reinforced by extensive adoption across 3,000+ hospitals and health systems in the U.S. and Canada and repeated Best in KLAS recognition for core categories. Category-leading positions in drug diversion monitoring, patient privacy monitoring, and RFID kit/tray management indicate sustained competitive advantage.
Innovation-Driven Growth: Ongoing launches such as the Prism AI platform and embedded generative capabilities for diversion investigations signal continuing innovation in pharmacy and compliance workflows. Additional releases like ShortageCheck, a redesigned 340B platform, and revenue optimization features broaden functionality and drive new use cases.
Strategic Partnerships: Collaborations with AWS, Premier, GraphiteRx/Mark Cuban Cost Plus Drugs, Pharma Logistics, Pfizer, and Healthmark are expanding distribution, capabilities, and ecosystem integration. These partnerships enable automated multi-product workflows and novel commercial arrangements that can accelerate adoption.
Magellan Health is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and...
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen. We partner with our clients to navigate the...
Avalere Health's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Revenue expanded in consecutive years, with double‑digit growth in 2023 followed by continued albeit slower growth in 2024. Trade coverage frames 2024 as a cooling market overall, suggesting the company’s trajectory reflects resilience amid a softer cycle.
Strong Market Position & Advantage: Industry rankings place the firm consistently in the MM+M Agency 100 top 20 in 2024–2025. External awards and frequent policy visibility reinforce stature in core North American healthcare‑agency and U.S. policy/access segments.
Future-Ready Strategy: Leadership additions, a unifying rebrand, and integration of advisory, medical, access, and marketing indicate a connected commercialization model. New offerings, AI/data‑driven tools, partnerships, and the “Every Patient Possible” mission signal preparation for evolving client needs.
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
AstraZeneca's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising strongly, with 2024 up to $54.1B and continued momentum into 2025 alongside management’s stated 2030 ambition. The trend is broad‑based across oncology and biopharma, with repeated beats and reaffirmed guidance supporting durability.
Strong Market Position & Advantage: Market position is top‑tier globally by value and leadership is pronounced in oncology, where the company ranks among the top three by revenue with multiple anchor assets. Scale and execution in the U.S. and other key markets underline competitive advantage.
Innovation-Driven Growth: Pipeline and approvals are driving expansion, with multiple 2025 U.S. FDA wins for ADCs, an expanded first‑line label for Enhertu, and a deep ASCO 2025 presence across ADC, I/O, targeted agents, and SERD.
RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered...
Novo Nordisk's Top Stability & Growth Strengths
Strong Market Position & Advantage: Novo Nordisk is characterized as a global leader in GLP‑1–based diabetes and obesity care, anchored by clinically differentiated products like Wegovy and a broad GLP‑1 portfolio. While shares fluctuate by geography, disclosures and independent analyses continue to frame the company as a category leader.
Innovation-Driven Growth: Cardiovascular outcomes data supporting Wegovy’s label expansion and the first approved oral GLP‑1 for chronic weight management, together with late‑stage assets (e.g., amycretin/zenagamtide, CagriSema), strengthen adoption arguments and extend the franchise.
Market Expansion: U.S. launch momentum for the Wegovy pill, EU approval, and planned international rollouts in 2026 are broadening access and the addressable market. Significant capacity additions, including acquired fill‑finish sites and new investments, are intended to support higher volumes across regions.
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from...
Sustainability isn’t just about tackling climate change, it represents a growing conscience around our actions and the impact they have on people, animals and planet. The personal, professional and governmental move to sustainable practice is driven by a desire to change our impact on the world, but we can’t do this without knowing the certainty of our actions. Transparency...
Maxor is a leading pharmacy care solutions company dedicated to improving patient outcomes and lowering the total cost of care through our clinically integrated set of pharmacy care services. Our teams help optimize the pharmacy experience for patients, our customers, their employees, and members whether it’s through our customized pharmacy benefit offerings; providing access to prescription medications and therapies through...
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
The Association for Accessible Medicines is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person’s life and the world around them. Generic and biosimilar medicines improve people’s lives, improving society and the economy in turn. AAM represents the manufacturers and distributors of finished generic pharmaceuticals and biosimilars, manufacturers and distributors of...
ERA Consulting offers consulting services and strategic advice in regulatory affairs and product development.
The American Pharmacists Association (APhA) is the only organization advancing the entire pharmacy profession—helping pharmacists find success and satisfaction in their work while advocating for changes that benefit them and their patients. At APhA, we’re committed to helping pharmacists deliver outstanding patient care, receive due recognition, and work at a full scope of practice. As every pharmacist’s most powerful ally,...
ASCP is the only international professional society devoted to optimal medication management and improved health outcomes for all older persons. Founded in 1969, ASCP is a non-profit membership organization currently based in Alexandria, VA. ASCP represents over 9,000 pharmacy professionals, including students, serving the unique medication needs of the senior population. Our members range in the services they provide and serve...
